Las Vegas, NV -- (SBWIRE) -- 10/04/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Plug Power Inc (NASDAQ:PLUG), Genco Shipping & Trading Limited (NYSE:GNK), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), Celsion Corporation (NASDAQ:CLSN).
Plug Power Inc (NASDAQ:PLUG) managed to keep its fall at -2.86% on traded volume of 3.27 million shares. The stock settled at $0.680 after floating in a range of $0.65 to $0.70. After recent close, it has reached market capitalization of $54.95 billion. Its 52-week range has been $0.12 to $0.90. Plug Power Inc. (Plug Power), is a provider of alternative energy technology focused on the design, development, commercialization and manufacture of fuel cell systems for the industrial off-road (forklift or material handling) market.
Will PLUG Get Buyers Even After The Recent Rally? Find Out Here
Genco Shipping & Trading Limited (NYSE:GNK) traded down on a volume of 2.83 million, lower than its standard daily volume. Shares have dropped -7.65% to $3.50. Over the last twelve months the stock has lost -4.89% and faced a worst price of $3.41. Genco Shipping & Trading Limited (GS&T) transports iron ore, coal, grain, steel products and other drybulk cargoes along worldwide shipping routes through the ownership and operation of drybulk carrier vessels.
Will GNK Get Buyers Even After The Recent Rally? Find Out Here
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) settled 1.80% higher at $3.39 on traded volume of 2.98 million shares during the last trading day, while its average trading volume remained 2.95 million shares. The stock has its 12-month low at $0.37 and 52-week high price was $3.65. It traded in a range of $3.35 to $3.65 during the last trading day. Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy.
Will CPRX Continue To Move Higher? Find Out Here
Celsion Corporation (NASDAQ:CLSN) saw its price gain on traded volume as 2.97 million shares changed hands when compared with its average daily volume of 1.62 million shares. The stock was up 4.17% to $1.25. It has fallen over the last 12 months, dropping -77.02% and marked new low $0.75. Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer.
Will CLSN Continue To Move Higher? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)